A Medical Device Daily

MDS Capital, a venture capital firm targeting health and life science investments, reported management promotions and that, effective immediately, it will be changing its name to Lumira Capital. The management changes include: the promotions of Gerry Brunk (Cambridge, Massachusetts), Beni Rovinski (Toronto), and Nandini Tandon (Mountain View, California) to the role of managing director where they will join Brian Underdown (Toronto) who continues in that role; Daniel Hetu (Montreal) to the role of venture partner; and Jack Jenuth and Charles Trimble to the role of senior analysts. The name change to Lumira Capital is the final part of a repositioning to enable the firm to build on its strength as a leading North American investor in biopharmaceutical and medical device companies, the company said. The company’s new web site is www.lumiracapital.com.

“These management changes have been in the works for some time and reflect the transition that has been occurring at our firm over the past couple of years as each of these investment team members has established themselves as key contributors to our recent successes and the value creation we have enjoyed with investee partners,” said Peter van der Velden, president/CEO of Lumira Capital.